Biosimilar Market Growth to Record CAGR of 32.00% up to 2028
Data Bridge Market Research analyses that the Biosimilar market is expected to undergo a CAGR of 32.00% during the forecast period of 2022-2029. This indicates that the market value, which was USD 37,270.20 million in 2021, would rocket up to USD 343,520.90 million by 2029. “Oncology” dominates the therapy type segment of the Biosimilar market owing to the increase in number of research studies, increasing research and development activities by key players focused on oncology and advancements in healthcare technologies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Sample Details
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biosimilar-market
COVID-19 Impact on Biosimilar Market
· COVID-19 has had a negative impact on the market. Reduced focus on non-essential medical procedures and postponement of healthcare procedures has put a dent on the market growth rate. Moreover, halt on the number of research and development proficiencies further restricted the scope of growth in the pandemic phase.
Recent Developments
· In July 2020, the FDA approved the adalimumab biosimilar, Hulio, developed by Fujifilm Kyowa Kirin Biologics, which is indicated for the subcutaneous treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.
· In May 2020, Fresenius Kabi received the acceptance of the regulatory submissions for its proposed pegfilgrastim biosimilar (MSB11455) by both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), respectively.
Global Biosimilar Market Scope
· The Biosimilar market is segmented on the basis of product type, drug class, type of manufacturing, procedure, disease, indication, therapy type and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product type
· Magnetic Resonance Imaging Scanners
· Computed Tomography Scanners
· Position Emission Tomography Scanners
· Biosimilar (EEG)
· Electromyography Devices (EMG)
· Magnetoencphalography Devices
· Transcranial Doppler Devices
· Intracranial Pressure Monitors (ICP)
· Electrodes
· Sensors
· Gels
· Cables
· Based on product type, Biosimilar market is segmented into MRI scanners, CT scanners, PET scanners, Biosimilar (EEG), electromyography devices (EMG), MEG devices, TCD devices, intracranial pressure monitors (ICP), electrodes, sensors, gels and cables.
Drug class
· Insulin
· Recombinant Human Growth Hormone (RHGH)
· Granulocyte Colony-Stimulating Factor
· Interferon
· Erythropoietin
· Etanercept
· Monoclonal Antibodies
· Follitropin
· Glucagon
· Calcitonin
· Teriparatide
· Enoxaparin Sodium
· On the basis of drug class, the Biosimilar market is segmented into insulin, recombinant human growth hormone (RHGH), granulocyte colony-stimulating factor, interferon, erythropoietin, etanercept, monoclonal antibodies, follitropin, glucagon, calcitonin, teriparatide and enoxaparin sodium. Monoclonal antibodies segment is sub-segmented into rituximab, infliximab, adalimumab, trastuzumab and other monoclonal antibodies.
Type of manufacturing
· In-House Manufacturing
· Contract Manufacturing
· On the basis of type of manufacturing, the Biosimilar market is segmented into in-house manufacturing and contract manufacturing.
Procedure
· Invasive
· Non-Invasive
· Based on procedure, Biosimilar market is segmented into Invasive and non-invasive.
Disease
· Stroke
· Dementia
· Epilepsy
· On the basis of disease, the Biosimilar market is segmented into stroke, dementia and epilepsy.
Indication
· Atrial Septal Defect (ASD)
· Ventricular Septal Defect (VSD)
· Patent Foramen Ovale (PFO)
· Aortic Valve Stenosis
· Others
· On the basis of indication, the Biosimilar market is segmented into atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO), aortic valve stenosis and others.
Therapy type
· Oncology
· Immunology
· Haematology
· Hormone Therapy
· Metabolic Disorders
· Others
· On the basis of therapy type, the Biosimilar market is segmented into oncology, immunology, haematology, hormone therapy, metabolic disorders, and others.
End users
· Hospitals
· Clinics
· Diagnostic Centres
· Others
· On the basis of end users, the Biosimilar market is segmented into hospitals, clinics, diagnostic centres and others
Biosimilar Market Regional Analysis/Insights
· The countries covered in the Biosimilar market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Biosimilar Market Share Analysis
· The Biosimilar market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Biosimilar market.
Some of the major players operating in the Biosimilar market are
· Novartis AG (Switzerland),
· Orion Pharma AB (Sweden),
· Pfizer Inc. (US),
· Samsung Bioepis. (South Korea),
· Coherus BioSciences, Inc. (US),
· Amgen Inc. (US),
· Eli Lilly and Company. (US),
· Takeda Pharmaceutical Company Limited. (Japan),
· Bristol-Myers Squibb Company (US),
· Merck KGaA (Germany),
· Teva Pharmaceutical Industries Ltd. (US),
· Biocon. (India),
· Bayer AG (Germany),
· AbbVie Inc. (US),
· Allergan (Ireland),
· Dr. Reddy’s Laboratories Ltd. (India),
· Boehringer Ingelheim International GmbH. (Germany)
· Biogen (US)
Full Access of Report @
https://www.databridgemarketresearch.com/reports/global-biosimilar-market
MAJOR TOC OF THE REPORT
· INTRODUCTION
· MARKET SEGMENTATION
· EXECUTIVE SUMMARY
· PREMIUM INSIGHTS
· MARKET OVERVIEW
· QUESTIONNAIRE
Get TOC Details
https://www.databridgemarketresearch.com/toc/?dbmr=global-biosimilar-market
Explore More Reports:
· Asia-Pacific fertility Testing Devices Market Is Likely to Upsurge, Growth Tactics, Future Strategies, Size, Share and competitive Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-fertility-testing-devices-market
· North America Fertility Testing Devices Market Destine to Reach, Size, Share, Industry Growth Rate, Demand, Trends & Revenue Forecast https://www.databridgemarketresearch.com/reports/north-america-fertility-testing-devices-market
· Europe Fertility Testing Devices Market to Obtain Overwhelming Growth of, Size, Share, Trends, Growth Forecast, Opportunities and Competitive Outlook https://www.databridgemarketresearch.com/reports/europe-fertility-testing-devices-market
· Low-Density Lipoprotein (LDL) Test Market to Exhibit a Striking Size, Share, Trends, Competitive Scenario, Challenges and Industry Growth Analysis https://www.databridgemarketresearch.com/reports/global-ldl-test-market
· North America Low Density Lipoprotein (LDL) Test Market is Forecasted to Reach Nearly, Size, Share, Trends, Development Strategies and Competitive Scenario https://www.databridgemarketresearch.com/reports/north-america-ldl-test-market
· Asia-Pacific Low Density Lipoprotein (LDL) Test Market is Projected to Reach at , Key Drivers, Types, Segment, Size, Share, Growth, Challenges and Opportunity Analysis https://www.databridgemarketresearch.com/reports/asia-pacific-ldl-test-market
· Europe Low Density Lipoprotein (LDL) Test Market Set to Reach Valuation of, Size, Share, Demand, Future Growth, Key Players and Revenue Forecast https://www.databridgemarketresearch.com/reports/europe-ldl-test-market
· Middle East and Africa Low Density Lipoprotein (LDL) Test Market to See Promising Growth of, Size, Share, Growth, Trends, Gross Revenue and Key Players Outlook https://www.databridgemarketresearch.com/reports/middle-east-and-africa-ldl-test-market
· Laboratory Information Systems (LIS) Market Is Expected to Grow at a Highest, Size, Share, Growth Statistics, Emerging Trends and Value Forecast https://www.databridgemarketresearch.com/reports/laboratory-information-systems-lis-market
· North America Laboratory Information System (LIS) Market to Garner, Share, Size, Growth, Key Players, and Trends forecast https://www.databridgemarketresearch.com/reports/north-america-laboratory-information-systems-lis-market
· Europe Laboratory Information System (LIS) Market Is Expected to Grasp the Value by Size, Share, Key Growth Drivers, Trends and Competitive Outlook https://www.databridgemarketresearch.com/reports/europe-laboratory-information-system-market
· Asia Pacific Laboratory Information System (LIS) Market to Receive Overwhelming Growth by , Size, Share, Trends, Growth and Revenue Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-laboratory-information-system-market
